pharmatechoutlook
4APRIL - 2023TECH OUTLOOK12 CXO INSIGHTSImmunotherapy in Lung Cancer: Building towards a Patient-Tailored FutureJames Holland, PhD, Senior Medical Writer, Ashfield MedComms, an Inizio company and Kindiya Geghman, PhD, CMPP, Vice President, Medical & Scientific Services, Ashfield MedComms, an Inizio company25Expanding the Promise of Immunotherapy Beyond the Oncology RealmJames Riddle, MCSE, CIP, CPIA, CRQM, Vice President, Research Services & Strategic Consulting, Advarra28Dentritic Cell Cancer Vaccine-- Promising Immunotherapy StrategyDerya DLEK KANÇAI, PhD, Laboratory Manager, Acibadem Healthcare Group17COV ER STORYJohn Mumm, President and CEODeka BiosciencesMADE-TO-MEASURE CYTOKINE THERAPY
< Page 3 | Page 5 >